This company listing is no longer active
Mediclinic International Past Earnings Performance
Past criteria checks 5/6
Key information
16.1%
Earnings growth rate
16.1%
EPS growth rate
Healthcare Industry Growth | 8.5% |
Revenue growth rate | 2.6% |
Return on equity | 5.2% |
Net Margin | 4.7% |
Next Earnings Update | 16 Nov 2022 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Mediclinic International makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 22 | 3,233 | 151 | 213 | 0 |
31 Dec 21 | 3,199 | 135 | 212 | 0 |
30 Sep 21 | 3,165 | 118 | 211 | 0 |
30 Jun 21 | 3,080 | 93 | 208 | 0 |
31 Mar 21 | 2,995 | 68 | 205 | 0 |
31 Dec 20 | 2,987 | -173 | 198 | 0 |
30 Sep 20 | 2,979 | -414 | 190 | 0 |
30 Jun 20 | 3,031 | -367 | 190 | 0 |
31 Mar 20 | 3,083 | -320 | 190 | 0 |
31 Dec 19 | 3,070 | -97 | 329 | 0 |
30 Sep 19 | 3,057 | 126 | 468 | 0 |
30 Jun 19 | 2,995 | -12 | 593 | 0 |
31 Mar 19 | 2,932 | -151 | 717 | 0 |
31 Dec 18 | 2,897 | -380 | 728 | 0 |
30 Sep 18 | 2,861 | -610 | 739 | 0 |
30 Jun 18 | 2,869 | -551 | 741 | 0 |
31 Mar 18 | 2,876 | -492 | 743 | 0 |
31 Dec 17 | 2,874 | -211 | 742 | 0 |
30 Sep 17 | 2,871 | 69 | 741 | 0 |
30 Jun 17 | 2,810 | 149 | 715 | 0 |
31 Mar 17 | 2,749 | 229 | 689 | 0 |
31 Dec 16 | 2,565 | 210 | 667 | 0 |
30 Sep 16 | 2,380 | 191 | 644 | 0 |
30 Jun 16 | 2,244 | 184 | 599 | 0 |
31 Mar 16 | 2,107 | 177 | 554 | 0 |
31 Dec 15 | 2,080 | 211 | 527 | 0 |
Quality Earnings: ANHG.Y has high quality earnings.
Growing Profit Margin: ANHG.Y's current net profit margins (4.7%) are higher than last year (2.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ANHG.Y has become profitable over the past 5 years, growing earnings by 16.1% per year.
Accelerating Growth: ANHG.Y's earnings growth over the past year (122.1%) exceeds its 5-year average (16.1% per year).
Earnings vs Industry: ANHG.Y earnings growth over the past year (122.1%) exceeded the Healthcare industry 1.2%.
Return on Equity
High ROE: ANHG.Y's Return on Equity (5.2%) is considered low.